FHIT and cancer: The unique phenotype of Fhit-deficient cells, with their rapid and prolonged block in S/G2 after UVC or mitomycin C treatment, coupled with drastically reduced apoptotic response, suggests that Fhit loss also contributes to multiple cell programs that are important in the development of precancer and cancer.